The in Vitro Synthesis of Hemoglobin by Human Bone Marrow in Thalassemia.
نویسندگان
چکیده
I N THALASSEMIA an inability to form hemoglobin at a normal rate is suggested by the marked degree of erythroid hypochromia in the presence of normal or increased serum iron. On purely theoretical grounds, Rich1 and later Itano2 suggested that in this syndrome there exists a defect in the peptide chains of hemoglobin. This concept was further elaborated by Ingram and co-workers3 who suggested that this decreased rate of synthesis of the peptide chains might be due to either (a) an electrophoretically “silent” structural change within individual peptide chains, or (b) a partial deletion or mumtalion cf a structural gene such that messenger RNA or the complete peptide could not be formed at a normal rate. Quantitative amino acid analysis of isolated peptide chains of hemoglobin from several patients with thalassemia has failed to reveal any abnormal seqtmences.4 Thus, a strumctural change in the amino acid sequence, such as found in Hb S, C, etc., has not been found in thalassemia. On the other hand, if abnormal messenger RNA is prodtmced, this might be expected to attach normally to the polyribosomes which then would be incapable of synthesizing peptide chains at a normal rate (the so-called “constipated ribosomes”). Marks and co-workers have, indeed, recently demonstrated that polyribosomes prepared from thalassemia reticulocytes synthesize globin at a rate lower than that seen in other hemolytic anemias. Furthermore, these workers reported that whereas there was a marked decrease in the rate of synthesis of hemoglobin A, there was no definite change in the rate of synthesis of hemoglobin F, when meastmred in the reticulocyte or ribosomal system. Reticulocytes, however, represent the penultimate stage of erythroid maturation. Globin synthesis is markedly reduced from the rate found in more immature cells7 where the bulk of hemoglobin synthesis occurs. Furthermore, there is no definite evidence that the rate of synthesis of the individual hemoglobins (i.e., Hb A, A2 and F) in the reticulocytes is the same as that rate in the more immature erythroid forms. It is also conceivable that if the messenger RNA for globin synthesis in thalassemia was somewhat less stable than that formed in normal nucleated erythroid cells, reticulocytes in thalas-
منابع مشابه
Bone Marrow Transplant (BMT) is the Main Cureavailable for Thalassamia
Introduction: The thalassamias refer to a diverse group of hemoglobin disorders characterized by a reduced synthesis of one or more of globin chains (α,β, γ, δβ,γδβ, δ and εγδβ).The main cure available today for thalassamia is bone marrow transplantation (BMT) from compatible donor.On December 3, 1981 a 14-month-old child with β-thalassemia major recieved BMT from his HLA-identical sister in...
متن کاملSol-Gel Synthesis, in vitro Behavior, and Human Bone Marrow-Derived Mesenchymal Stem Cell Differentiation and Proliferation of Bioactive Glass 58S
Background: Bioactive glasses 58S, are silicate-based materials containing calcium and phosphate, which dissolved in body fluid and bond to the bone tissue. This type of bioactive glass is highly biocompatible and has a wide range of clinical applications. Methods: The 58S glass powders were synthesized via sol-gel methods, using tetraethyl orthosilicate, triethyl phosphate, and calcium nitrate...
متن کاملBone Marrow Transplantation in Thalassemia (Part 2)
During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...
متن کاملBone Marrow Transplantation in Thalassemia (Part 1)
During the last two decades conventional therapy has improved the prognosis of thalassemia. However, despite such improvement it still remains a progressive disease with treatment-related complications such as hepatitis, liver fibrosis, and cardiac disease. Bone marrow transplantation (BMT) can prevent or delay progression of the aforementioned complications. The importance of clinical research...
متن کاملThe Interaction ofllemoglobin E With ; 9 Thalassemia : A
A 5-yr-old girl with hemoglobin E-$ thalassemia was discovered in a family of mixed origin. The father is Iranian (6-thalassemia trait) and the mother is Burmese (hemoglobin-E trait). Hemoglobin synthesis was studied in vitro in the blood of the proposita and family members. In the subjects with hemoglobin E trait the ratio of the quantity of hemoglobin A to hemoglobin E was 3:1. However. the A...
متن کاملEvaluation of In Vitro Differentiation of Cardiomyocyte-like cells Derived from Human Bone Marrow Mesenchymal Stem Cells
Purpose: To investigate the in vitro differentiation process of cardiomyocyte-like cells derived from human bone marrow mesenchymal stem cells under the influence of 5-azacytidine (5-aza). Materials and Methods: After purification, human bone marrow mesenchymal stem cells were exposed to 5-aza at a concentration of 5 μmol for 5 weeks to induce cardiomyocyte differentiation. To induce differenti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 25 شماره
صفحات -
تاریخ انتشار 1965